Klinische studies myelodysplastisch syndroom (MDS)

Onbehandelde patiënten

GLORA-4 (APG2575MG301)

A Global Multicenter, Double-Blind, Randomized, Registrational  Phase 3 Study of Lisaftoclax (APG-2575) in Combination with Azacitidine (AZA) in Patients with Newly Diagnosed Higher Risk Myelodysplastic Syndrome (HR-MDS)

• Principal investigator: prof. dr. Mariëlle Beckers
• More information: NCT06641414
• Internal reference number: S70060

Behandelde patiënten

Momenteel geen actieve studies